Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erratum to: Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice?
Amirdzhanova VN, Karateev AE, Pogozheva EY, Filatova ES, Samigullina RR, Mazurov VI, Anoshenkova ON, Lapkina NA, Baranov AA, Grineva TY, Lila AM, Nasonov EL. Amirdzhanova VN, et al. Among authors: mazurov vi. Dokl Biochem Biophys. 2023 Dec;513(1):363. doi: 10.1134/S1607672923050010. Epub 2024 Jan 24. Dokl Biochem Biophys. 2023. PMID: 38267787 Free PMC article. No abstract available.
Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice?
Amirdzhanova VN, Karateev AE, Pogozheva EY, Filatova ES, Samigullina RR, Mazurov VI, Anoshenkova ON, Lapkina NA, Baranov AA, Grineva TY, Lila AM, Nasonov EL. Amirdzhanova VN, et al. Among authors: mazurov vi. Dokl Biochem Biophys. 2023 Aug;511(1):180-186. doi: 10.1134/S1607672923700308. Epub 2023 Oct 13. Dokl Biochem Biophys. 2023. PMID: 37833604 Free PMC article.
[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial].
Kulagin AD, Bakirov BA, Davydkin IL, Elykomov IV, Konstantinova TS, Korobkin AV, Kosinova MV, Mazurov VI, Minaeva NV, Proidakov AV, Ptushkin VV, Shatokhin YV, Lin'kova YN, Zinkina-Orikhan AV, Morozova MA. Kulagin AD, et al. Among authors: mazurov vi. Ter Arkh. 2021 Nov 15;93(11):1340-1348. doi: 10.26442/00403660.2021.11.201226. Ter Arkh. 2021. PMID: 36286657 Clinical Trial. Russian.
Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study.
Mazurov VI, Dubinina TV, Erdes S, Lapshina SA, Soroka NF, Kunder EV, Smirnov AV, Eremeeva AV, Zinkina-Orikhan AV, Morozova MA, Gaydukova IZ. Mazurov VI, et al. Clin Exp Rheumatol. 2023 Mar;41(3):718-726. doi: 10.55563/clinexprheumatol/ljpqqe. Epub 2022 Aug 31. Clin Exp Rheumatol. 2023. PMID: 36062743 Clinical Trial.
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study.
Lomakin NV, Bakirov BA, Protsenko DN, Mazurov VI, Musaev GH, Moiseeva OM, Pasechnik ES, Popov VV, Smolyarchuk EA, Gordeev IG, Gilyarov MY, Fomina DS, Seleznev AI, Linkova YN, Dokukina EA, Eremeeva AV, Pukhtinskaia PS, Morozova MA, Zinkina-Orikhan AV, Lutckii AA. Lomakin NV, et al. Among authors: mazurov vi. Inflamm Res. 2021 Dec;70(10-12):1233-1246. doi: 10.1007/s00011-021-01507-5. Epub 2021 Sep 29. Inflamm Res. 2021. PMID: 34586459 Free PMC article. Clinical Trial.
[The efficacy of non-sreroidal anti-inflammatory drugs].
Gaydukova IZ, Mazurov VI. Gaydukova IZ, et al. Among authors: mazurov vi. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(5):134-140. doi: 10.17116/jnevro2019119051134. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31317902 Russian.
A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study.
Lila AM, Mazurov VI, Denisov LN, Nesmeyanova OB, Ilivanova EP, Eremeeva AV, Usacheva JV, Dokukina EA, Chernyaeva EV, Ivanov RA. Lila AM, et al. Among authors: mazurov vi. Rheumatol Int. 2019 Sep;39(9):1537-1546. doi: 10.1007/s00296-019-04359-9. Epub 2019 Jul 10. Rheumatol Int. 2019. PMID: 31292709 Clinical Trial.
Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy).
Karateev AE, Pogozheva EY, Filatova EA, Amirjanova VN, Lila AM, Antipova OV, Babaeva AR, Volkorezova AV, Davydova AF, Davtyan VG, Zonova EV, Ivanova ON, Kalinina NN, Kiseleva NI, Knyazeva LA, Kulikov AI, Nesmeyanova OB, Mazurov VI, Masneva LV, Menshikova LV, Obuhova IV, Otteva EN, Salnikova TS, Shсhendrygin IN, Yakupova SP. Karateev AE, et al. Among authors: mazurov vi. Ter Arkh. 2018 Jun 20;90(6):65-73. doi: 10.26442/terarkh201890665-73. Ter Arkh. 2018. PMID: 30701907
Novelties in the field of autoimmunity - 1st Saint Petersburg congress of autoimmunity, the bridge between east and west.
Dahan S, Segal Y, Watad A, Azrielant S, Shemer A, Maymon D, Stroev YI, Sobolevskaya PA, Korneva EA, Blank M, Gilburd B, Shovman O, Amital H, Ehrenfeld M, Tanay A, Kivity S, Pras E, Chapman J, Damoiseaux J, Cervera R, Putterman C, Shapiro I, Mouthon L, Perricone R, Bizzaro N, Koren O, Riemekasten G, Chereshnev VA, Mazurov VI, Goloviznin M, Gurevich V, Churilov LP, Shoenfeld Y. Dahan S, et al. Among authors: mazurov vi. Autoimmun Rev. 2017 Dec;16(12):1175-1184. doi: 10.1016/j.autrev.2017.10.001. Epub 2017 Oct 14. Autoimmun Rev. 2017. PMID: 29037903 Review. No abstract available.
135 results